ulunar breezhaler
novartis europharm limited - glycopyrronium bromid, indacaterol maleate - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - ulunar breezhaler er indiceret som vedligeholdelsesbronkodilatorbehandling for at lindre symptomer hos voksne patienter med kronisk obstruktiv lungesygdom (copd).
zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - medicin for obstruktiv sygdomme, - maintenance treatment of asthma in adults whose disease is not adequately controlled.
xoterna breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromid - pulmonal sygdom, kronisk obstruktiv - adrenergica i kombinationer med antikolinergika inkl. tredobbelte kombination med kortikosteroider - xoterna breezhaler er indiceret som bronkodilaterende vedligeholdelsesbehandling at lindre symptomer hos voksne patienter med kronisk obstruktiv lungesygdom (kol).
ultibro breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromid - pulmonal sygdom, kronisk obstruktiv - adrenergica i kombinationer med antikolinergika inkl. tredobbelte kombination med kortikosteroider, medicin til obstruktiv sygdomme, - ultibro breezhaler er indiceret som bronkodilaterende vedligeholdelsesbehandling at lindre symptomer hos voksne patienter med kronisk obstruktiv lungesygdom (kol).
enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - medicin for obstruktiv sygdomme, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
glycopyrronium bromide "martindale" 200 mikrogram/ml injektionsvæske, opløsning
ethypharm - glycopyrroniumbromid - injektionsvæske, opløsning - 200 mikrogram/ml
trimbow
chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarate dihydrat, glycopyrronium bromid - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.
glycopyrroniumbromid ethypharm 200 mikrogram/ml injektionsvæske, opløsning
orifarm a/s - glycopyrroniumbromid - injektionsvæske, opløsning - 200 mikrogram/ml
enurev breezhaler
novartis europharm ltd - glycopyrronium bromid - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - enurev breezhaler er indiceret som vedligeholdelsesbronkodilatorbehandling for at lindre symptomer hos voksne patienter med kronisk obstruktiv lungesygdom (copd).
seebri breezhaler
novartis europharm limited - glycopyrronium bromid - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - seebri breezhaler er indiceret som vedligeholdelsesbronkodilatorbehandling for at lindre symptomer hos voksne patienter med kronisk obstruktiv lungesygdom (copd).